Eli Lilly (LLY) Stock Price Prediction in 2025 The current Wall Street consensus 1-year price target of Eli Lilly stock is $1030.00, which is 10.40% higher than today’s price of $933.00.

DOCTORS DRAW ATTENTION TO SAFETY ISSUES ASSOCIATED WITH POPULAR WEIGHT-LOSS DRUGS The FDA is reconsidering its decision to take the drug off the shortage list after pushback, but Eli Lilly ...

Eli Lilly is expanding its innovation digs to Beijing, opening two research centers called the Eli Lilly China Medical Innovation Center and Lilly Gateway Labs. The newest Gateway Lab is the ...

Eli Lilly has become a household name thanks to breakthrough diabetes and obesity care medicines. The stock has trounced the broader market over the past year, and shares have become a bit pricey.

Eli Lilly (NYSE: LLY) sells treatments for a wide variety of therapeutic areas, but one portfolio in particular has driven major gains in recent times. And that's the company's weight loss drugs.

I’m Conway Gittens reporting from the New York ... In other business headlines: Eli Lilly has launched a direct-to-consumer ...

Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2024 financial results on Oct. 30, 2024. Lilly will also conduct a conference call that day with the investment community and ...

That’ll do it for your daily briefing. From the New York Stock Exchange, I’m Conway Gittens with TheStreet. Related: Analysts reveal Eli Lilly stock price targets after earnings ...

Earnings Report 1.401 USD Q3 2024 Earnings Release 10/30/2024 Earnings Report 5.419 USD Q4 2024 Earnings Release 01/30/2025 Earnings Report 5.365 USD Q1 2025 Earnings Release 04/24/2025 Earnings ...

Eli Lilly logo is shown on one of the company's offices in San Diego, California, US, Sept 17, 2020. [Photo/Agencies] US pharmaceutical company Eli Lilly and Co recently announced a roughly $200 ...

And Eli Lilly has partnered with the government of the United Kingdom to see if its blockbuster weight loss drug could help get some people We recently published an article titled, Jim Cramer’s ...